255
References
- Suzuki MM, Bird A (2008) DNA methylation
landscapes: provocative insights from epig-
enomics. Nat Rev Genet 9:465–476 - Sharma S, Kelly TK, Jones PA (2010)
Epigenetics in cancer. Carcinogenesis 31:27–36 - Feinberg AP, Tycko B (2004) The history of
cancer epigenetics. Nat Rev Cancer 4:143–153 - Kailasam A, Mittal SK, Agrawal DK (2015)
Epigenetics in the pathogenesis of esophageal
adenocarcinoma. Clin Transl Sci 8:394–402 - Agarwal A, Polineni R, Hussein Z, Vigoda I,
Bhagat TD, Bhattacharyya S, Maitra A, Verma
A (2012) Role of epigenetic alterations in the
pathogenesis of Barrett's esophagus and esoph-
ageal adenocarcinoma. Int J Clin Exp Pathol
5:382–396 - Peng D, Hu TL, Jiang A, Washington MK,
Moskaluk CA, Schneider-Stock R, El-Rifai W
(2011) Location-specific epigenetic regulation
of the metallothionein 3 gene in esophageal
adenocarcinomas. PLoS One 6:e22009 - Kaz AM, Grady WM (2014) Epigenetic bio-
markers in esophageal cancer. Cancer Lett
342:193–199 - Wong DJ, Barrett MT, Stoger R et al (1997)
p16INK4a promoter is hypermethylated at a
high frequency in esophageal adenocarcino-
mas. Cancer Res 57:2619–2622 - Klump B, Hsieh CJ, Holzmann K, Gregor M,
Porschen R (1998) Hypermethylation of the
CDKN2/p16 promoter during neoplastic pro-
gression in Barrett’s esophagus.
Gastroenterology 115:1381–1386 - Eads CA, Lord RV, Wickramasinghe K, Long
TI, Kurumboor SK, Bernstein L, Peters JH,
DeMeester SR, DeMeester TR, Skinner KA,
Laird PW (2001) Epigenetic patterns in the
progression of esophageal adenocarcinoma.
Cancer Res 61:3410–3418 - Wild Christopher P, Hardie LJ (2003)
Molecular events associated with the develop-
ment of Barrett’s esophagus and esophageal
adenocarcinoma. Nat Rev Cancer 3:676–684 - Xu E, Gu J, Hawk ET, Wang KK, Lai M,
Huang M, Ajani J, Wu X (2013) Genome-wide
methylation analysis shows similar patterns in
Barrett's esophagus and esophageal adenocar-
cinoma. Carcinogenesis 34:2750–2756 - Corn PG, Heath EI, Heitmiller R, Fogt F,
Forastiere AA, Herman JG, Wu TT (2001)
Frequent hypermethylation of the 5′ CpG
island of E-cadherin in esophageal adenocarci-
noma. Clin Cancer Res 7:2765–2769
14. Kuester D, El-Rifai W, Peng D, Ruemmele P,
Kroeckel I, Peters B, Moskaluk CA, Stolte M,
Mönkemüller K, Meyer F, Schulz HU,
Hartmann A, Roessner A, Schneider-Stock R
(2009) Silencing of MGMT expression by pro-
moter hypermethylation in the metaplasia-
dysplasia- carcinoma sequence of Barrett’s
esophagus. Cancer Lett 275:117–126
15. Smith E, Ruszkiewicz AR, Jamieson GG, Drew
PA (2014) IGFBP7 is associated with poor
prognosis in esophageal adenocarcinoma and is
regulated by promoter DNA methylation. Br
J Cancer 110:775–782
16. Brock MV, Gou M, Akiyama Y, Muller A, Wu
TT, Montgomery E, Deasel M, Germonpré P,
Rubinson L, Heitmiller RF, Yang SC, Forastiere
AA, Baylin SB, Herman JG (2003) Prognostic
importance of promoter hypermethylation of
multiple genes in esophageal adenocarcinoma.
Clin Cancer Res 9:2912–2919
17. Wang JS, Guo M, Montgomery EA, Thompson
RE, Cosby H, Hicks L, Wang S, Herman JG,
Canto MI (2009) DNA promoter hypermeth-
ylation of p16 and APC predicts neoplastic
progression in Barrett’s esophagus. Am
J Gastroenterol 104:2153–2160
18. Kuester D, Dar AA, Moskaluk CC, Krueger S,
Meyer F, Hartig R, Stolte M, Malfertheiner P,
Lippert H, Roessner A, El-Rifai W, Schneider-
Stock R (2007) Early involvement of death-
associated protein kinase promoter
hypermethylation in the carcinogenesis of
Barrett’s esophageal adenocarcinoma and its
association with clinical progression. Neoplasia
9:236–245
19. Jin Z, Cheng Y, Olaru A, Kan T, Yang J, Paun
B, Ito T, Hamilton JP, David S, Agarwal R,
Selaru FM, Sato F, Abraham JM, Beer DG,
Mori Y, Shimada Y, Meltzer SJ (2008)
Promoter hypermethylation of CDH13 is a
common, early event in human esophageal
adenocarcinogenesis and correlates with
clinical risk factors. Int J Cancer 123:
2331–2336
20. Jin Z, Mori Y, Yang J, Sato F, Ito T, Cheng Y,
Paun B, Hamilton JP, Kan T, Olaru A, David S,
Agarwal R, Abraham JM, Beer D, Montgomery
E, Meltzer SJ (2007) Hypermethylation of the
nel-like 1 gene is a common and early event
and is associated with poor prognosis in early-
stage esophageal adenocarcinoma. Oncogene
26:6332–6340
21. Tischoff I, Hengge UR, Vieth M, Ell C, Stolte
M, Weber A, Schmidt WE, Tannapfel A (2007)
DNA Methylation in Esophageal Adenocarcinoma